VHLL-BCN

PARG-IN-7 (Example 38) is a Poly ADP-ribose glycohydrolase (PARG) inhibitor (IC50: < 0.1 μM). PARG-IN-7 inhibits cell viability of HCC1806-XRCC1 KD (knock down) cells with an IC50 < 1 μM. PARG-IN-7 can be used for cancer research.


Cat. No.: EX-A16293	Purity: >98%

	Chemical structure of VHLL-BCN

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock	Quantity	Order
500mg	get quote	inquire
1g	get quote	inquire

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	2874203-49-1
Purity	>98%
Formula	C35H45N5O6S
Mol Weight	663.827
Color	White to off-white
State	Solid
Solubility	soluable in DMSO
Shelf Life	>3 years if stored properly
Storage	Powder -20℃ 3 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. James Clifford SUTTON, et al. 4-substituted indole and indazole sulfonamido derivatives as parg inhibitors. Patent. WO2021055744
CoA	CoA of VHLL-BCN

Smiles:	O=C(N1[C@@H](C[C@H](C1)O)C(NCC2=CC=C(C3=C(C)N=CS3)C=C2)=O)[C@H](C(C)(C)C)NC(CNC(OC[C@@H]4[C@@]5([H])[C@]4([H])CCC#CCC5)=O)=O


		Search